Baillie Gifford's position in Exact Sciences is currently worth $77 Million. That's 0.06% of their equity portfolio (129th largest holding). The first Exact Sciences trade was made in Q3 2017. Since then Baillie Gifford bought shares seventeen more times and sold shares on nine occasions. The investor's estimated purchase price is $183 Million, resulting in a loss of 58%.